Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
   PubMed Web of Science ®Google Scholar
• Adami HO, Ponten J, Sparen P, Bergström R, Gustafsson L, Friberg LG. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960–1984. Cancer 1994;73:140–7.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O’Reilly M, . The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009;45:2671–8.
   PubMed Web of Science ®Google Scholar
• IARC. Cervix Cancer Screening.Lyon: IARC Press; 2005.
   Google Scholar
• Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, . American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342–62.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer: IARC CancerBase No.10; 2010.
   Google Scholar
• Anttila A, Ronco G. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009;45:2685–708.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Autier P, Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: Estimates for 2004. Ann Oncol 2007;18:1423–5.
   PubMed Web of Science ®Google Scholar
• Becker N. Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol 2003;129:691–702.
   PubMed Web of Science ®Google Scholar
• Schenck U, von Karsa L. Cervical cancer screening in Germany. Eur J Cancer 2000;36:2221–6.
   PubMed Web of Science ®Google Scholar
• Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, . Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784–96.
   PubMed Web of Science ®Google Scholar
• Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, . EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009;45:931–91.
   PubMed Web of Science ®Google Scholar
• Brenner H, Stegmaier C, Ziegler H. Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol 2005;16:981–6.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004–10.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O, Hakulinen T. Period analysis for ‘up-to-date’ cancer survival data: Theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004;40:326–35.
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epidemiol 2006;164:689–96.
   PubMed Web of Science ®Google Scholar
• Gondos A, Bray F, Brewster DH, Coebergh JW, Hakulinen T, Janssen-Heijnen ML, . Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 2008;44:1463–75.
   PubMed Web of Science ®Google Scholar
• Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, . Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 2012;23:472–9.
   PubMed Web of Science ®Google Scholar
• Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin LH, Parkin DM, . International classification of diseases for oncology, 3rd ed. Geneva: World Health Organization; 2000.
   Google Scholar
• Kosary CL. Cancer of the cervix uteri. In: Gloeckler RLA, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER Survival Monograph: Cancer survival among adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. SEER Program, NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute; 2007. p. 111–22.
   Google Scholar
• Dudeck J, Wagner G, Grundmann E, Hermanek P. Basisdokumentation für Tumorkranke, Prinzipien und Verschlüsselungsanweisungen für Klinik und Praxis, 5. Auflage; Zuckschwerdt Verlag: 1999.
   Google Scholar
• Brenner H, Soderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: Empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002;31:456–62.
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20:826–32.
   PubMed Web of Science ®Google Scholar
• Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961;6:101–21.
   PubMedGoogle Scholar
• Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Bethesda (MD): National Cancer Institute; 1959.
   Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O, Hakulinen T. A computer program for period analysis of cancer patient survival. Eur J Cancer 2002;38:690–5.
   PubMed Web of Science ®Google Scholar
• Gatta G, Capocaccia R, Hakulinen T, Sant M, Verdecchia A, De Angelis G, . Variations in survival for invasive cervical cancer among European women, 1978–89. EUROCARE Working Group. Cancer Causes Control 1999;10:575–81.
   PubMed Web of Science ®Google Scholar
• Bielska-Lasota M, Inghelmann R, Poll-Franse L, Capocaccia R. Trends in cervical cancer survival in Europe, 1983–1994: A population-based study. Gynecol Oncol 2007;105:609–19.
   PubMed Web of Science ®Google Scholar
• Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, . Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009;45:1042–66.
   PubMed Web of Science ®Google Scholar
• Vrdoljak E, Hamm W. Current state-of-the-art of concomitant chemoradiation in cervical carcinomas. Eur J Gynaecol Oncol 2003;24:475–9.
   PubMed Web of Science ®Google Scholar
• Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, . Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 2001;358:781–6.
   PubMed Web of Science ®Google Scholar
• Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, . Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005;(3):CD002225.
   Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802–12.
   PubMed Web of Science ®Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC) .Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis. Cochrane Database Syst Rev 2010;(1):CD008285.
   Google Scholar
• Pearcey R, Miao Q, Kong W, Zhang-Salomons J, Mackillop WJ. Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: Results of a population-based cohort study. J Clin Oncol 2007; 25:2383–8.
   PubMed Web of Science ®Google Scholar
• Kunos C, Tian C, Waggoner S, Rose PG, Lanciano R. Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: A gynecologic oncology group study. Int J Gynecol Cancer 2009;19:1258–63.
   PubMed Web of Science ®Google Scholar
• Ruckinger S, Tauscher M, Redel R, Munte A, Walchner-Bonjean M, Hess J, . Participation in cervical cancer screening by age and region – a cohort study with a 3 1/2 year follow-up on 2,223,135 women in Bavaria. Gesundheitswesen 2008;70:e17–21.
   Web of Science ®Google Scholar
• Balducci L. Geriatric oncology: Challenges for the new century. Eur J Cancer 2000;36:1741–54.
   PubMed Web of Science ®Google Scholar
• Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973–87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31–46.
   PubMedGoogle Scholar
• zur Hausen H. Papillomaviruses in the causation of human cancers – a brief historical account. Virology 2009;384: 260–5.
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–9.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, . Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796–802.
   PubMed Web of Science ®Google Scholar
• Lai CH, Chang CJ, Huang HJ, Hsueh S, Chao A, Yang JE, . Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery. J Clin Oncol 2007;25:3628–34.
   PubMed Web of Science ®Google Scholar
• Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, . Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996;88:1361–8.
   PubMedGoogle Scholar
• Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol 2011;11:129.
   PubMed Web of Science ®Google Scholar